Conference Coverage
Conference Coverage
Small PFS gain in metastatic prostate cancer with TKI and ICI
Expert questions the choice of an androgen receptor pathway inhibitor (ARPI) switch as the control arm of the study.
Conference Coverage
Combo Tx Best in Metastatic Prostate Cancer with HRR Mutations
PFS was better with abiraterone/prednisone and olaparib vs. monotherapy in men with metastatic castration-resistant prostate cancer with DNA...
Conference Coverage
Stockholm3 Prostate Test Bests PSA for Prostate Cancer Risk in North America
The Stockholm3 blood test, using a multiplex algorithm, shows benefits over PSA in a diverse, multi-ethnic cohort beyond a Swedish population...
Conference Coverage
High-dose RT and long-term ADT improve survival in high-risk prostate cancer
These results are “practice-affirming for many,” according to an expert commenting on the new findings.
Conference Coverage
Bladder Cancer: Is Active Surveillance the Way Forward?
Should clinicians promote active surveillance for non–muscle-invasive bladder tumors (NMIBT) and establish it as a comprehensive management...
Conference Coverage
The Case for Biomarker Testing in Gastroesophageal Cancer
Expert provides top three picks for biomarker testing for treatment selection.
Conference Coverage
Targeted Colorectal Cancer Combo Improves QoL
The results of a new trial may point the way to other dual therapies involving kinase inhibitors, says expert.
Conference Coverage
Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC
The findings of a new study indicate that nivolumab plus ipilimumab should really be “a new standard,” a medical oncologist says.
Conference Coverage
Nodal Radiation May Make BC Axillary Dissection Unnecessary
A major trial finds that there’s no need to do both in breast cancer patients with just one or two positive sentinel lymph nodes.
Conference Coverage
New Multiple Myeloma Staging Systems Outperform the Standard
Retrospective study shows that the proposed new systems offer more refined risk classifications in stages of myeloma.
